Q9PTN2 (VDRA_DANRE) Danio rerio (Zebrafish) (Brachydanio rerio)
Vitamin D3 receptor A UniProtKBInterProInteractive Modelling
453 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
58 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Vitamin D Receptor complex with lithocholic acid |
Heteromer Q15596; | 4×4OA; | ||||
| Assess | ||||||
| VDR complex |
Heteromer Q15788; | 2×AYK; | ||||
| Assess | ||||||
| Allene-Based Design of a Noncalcemic Vitamin D Receptor Agonist |
Heteromer Q15788; | 2×T0H; 2×ACT; | ||||
| Assess | ||||||
| Vitamin D receptor complex |
Heteromer Q15788; | 2×B0B; | ||||
| Assess | ||||||
| Crystal structure of zVDR L337H mutant-VD complex |
Heteromer Q15788; | 2×VDX; | ||||
| Assess | ||||||
| Structure-function study of Gemini derivatives with two different side chains at C-20, Gemini-0072 … |
Heteromer Q15596; | 2×G72; | ||||
| Assess | ||||||
| Structure-function of Gemini derivatives with two different side chains at C-20, Gemini-0072 and Ge… |
Heteromer Q15596; | 2×H97; | ||||
| Assess | ||||||
| VDR complex with Aromatic-D-Ring Analog |
Heteromer Q15788; | 1×ACT; 1×IV1; | ||||
| Assess | ||||||
| 1a,20S-dihydroxyvitamin D3 VDR complex |
Heteromer Q15788; | 2×D3V; | ||||
| Assess | ||||||
| VDR complex of a side-chain hydroxylated derivatives of lithocholic acid |
Heteromer Q15788; | 2×2WV; | ||||
| Assess | ||||||
| Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain |
Heteromer Q15788; | 2×91W; | ||||
| Assess | ||||||
| VDR LBD complex with 25-nitro derivative of 1,25D3 |
Heteromer Q15788; | 1×ACT; 1×UYO; | ||||
| Assess | ||||||
| Vitamin D receptor complex with 25-amine derivative of 1,25D3 |
Heteromer Q15788; | 2×ACT; 2×UYU; | ||||
| Assess | ||||||
| Crystal structure of the LBD of VDR of Danio rerio in complex with calcitriol |
Heteromer Q15788; | 2×VDX; | ||||
| Assess | ||||||
| Development of synthetically accessible non-secosteroidal hybrid molecules combining vitamin D rece… |
Heteromer Q15596; | 2×0U3; | ||||
| Assess | ||||||
| VDR complex - calcitroic acid |
Heteromer Q15648; | 1×2QI; | ||||
| Assess | ||||||
| Development of synthetically accessible non-secosteroidal hybrid molecules combining vitamin D rece… |
Heteromer Q15596; | 2×0S4; | ||||
| Assess | ||||||
| Potent Vitamin D Receptor Agonist |
Heteromer Q15788; | 2×M7E; | ||||
| Assess | ||||||
| VDR complex with BXL-62 |
Heteromer Q15788; | 1×U5W; | ||||
| Assess | ||||||
| Vitamin D receptor complex |
Heteromer Q15788; | 2×AYT; | ||||
| Assess | ||||||
| Diastereotopic and Deuterium Effects in Gemini |
Heteromer Q15596; | 2×BIV; | ||||
| Assess | ||||||
| Structural analysis and biological activities of BXL0124, a Gemini analog of Vitamin D |
Heteromer Q15596; | 2×6VH; | ||||
| Assess | ||||||
| Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear R… |
Heteromer Q15788; | 2×0VQ; | ||||
| Assess | ||||||
| Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear R… |
Heteromer Q15788; | 2×0VP; | ||||
| Assess | ||||||
| Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain |
Heteromer Q15788; | 2×9CZ; | ||||
| Assess | ||||||
| Vitamin D nuclear receptor complex 1 |
Heteromer Q15788; | 2×E05; | ||||
| Assess | ||||||
| Vitamin D nuclear receptor complex 3 |
Heteromer Q15788; | 2×LX3; | ||||
| Assess | ||||||
| Crystal structure of the ligand binding domain of the Vitamin D nuclear receptor in complex with Ge… |
Heteromer Q15788; | 2×BIV; | ||||
| Assess | ||||||
| crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 54 |
Heteromer Q15596; | 1×IFU; | ||||
| Assess | ||||||
| Crystal structure of Vitamin D nuclear receptor ligand binding domain bound to a locked side-chain … |
Heteromer Q15788; | 2×XE4; | ||||
| Assess | ||||||
| Diastereotopic and Deuterium Effects in Gemini |
Heteromer Q15596; | 2×BIV; | ||||
| Assess | ||||||
| Side-chain fluorine atoms of non-steroidal vitamin D3 analogs stabilize helix 12 of vitamin D recep… |
Heteromer Q15788; | 2×MG; 2×C5D; | ||||
| Assess | ||||||
| Diastereotopic and Deuterium Effects in Gemini |
Heteromer Q15596; | 2×BIV; | ||||
| Assess | ||||||
| VDR complex with BXL-62 |
Heteromer Q15788; | 1×U5W; | ||||
| Assess | ||||||
| Vitamin D nuclear receptor complex 2 |
Heteromer Q15788; | 2×E0E; | ||||
| Assess | ||||||
| Vitamin D receptor complex 5 |
Heteromer Q15788; | 2×DZW; | ||||
| Assess | ||||||
| Crystal structure of zVDR L337H mutant-Gemini72 complex |
Heteromer Q15788; | 2×H97; | ||||
| Assess | ||||||
| Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain |
Heteromer Q15788; | 2×9CW; | ||||
| Assess | ||||||
| Crystal structure of zVDR L337H mutant-gemini complex |
Heteromer Q15596; | 2×BIV; | ||||
| Assess | ||||||
| Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear R… |
Heteromer Q15788; | 2×0VO; | ||||
| Assess | ||||||
| VDR complex with LCA derivative |
Heteromer Q15788; | 2×FKC; | ||||
| Assess | ||||||
| Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear R… |
Heteromer Q15788; | 2×0VK; | ||||
| Assess | ||||||
| Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear R… |
Heteromer Q15788; | 2×484; | ||||
| Assess | ||||||
| Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear R… |
Heteromer Q15788; | 2×0VP; | ||||
| Assess | ||||||
| crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 analog 56 |
Heteromer Q15596; | 1×IG5; | ||||
| Assess | ||||||
| Diastereotopic and Deuterium Effects in Gemini |
Heteromer Q15596; | 2×BIV; | ||||
| Assess | ||||||
| VDR-ZK168281 complex |
Heteromer Q15788; | 2×M9Q; | ||||
| Assess | ||||||
| VDR complex with a side-chain hydroxylated derivative of lithocholic acid |
Heteromer Q15788; | 2×2UI; | ||||
| Assess | ||||||
| Vitamin D nuclear receptor complex 4 |
Heteromer Q15788; | 2×DZT; | ||||
| Assess | ||||||
| VDR complex with aromatic D-ring analog |
Heteromer Q15788; | 1×ACT; 1×IV5; | ||||
| Assess | ||||||
| crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 49 |
Heteromer Q15596; | 1×I72; | ||||
| Assess | ||||||
| Crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 55 |
Heteromer Q15596; | 1×IFK; | ||||
| Assess | ||||||
| crystal structure of VDR complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 57 |
Heteromer Q15596; | 1×IG0; | ||||
| Assess | ||||||
| Structure of zVDR LBD-Calcitriol in complex with chimera 13 | monomer | 1×VDX; 2×ACT; | ||||
| Assess | ||||||
| Structure of zVDR LBD-Calcitriol in complex with chimera 12 | monomer | 1×VDX; 1×ACT; | ||||
| Assess | ||||||
| Structure of zVDR LBD-calcitriol in complex with chimera 11 | monomer | 1×VDX; 1×ACT; | ||||
| Assess | ||||||
| Structure of zVDR LBD-Calcitriol in complex with chimera 18 | monomer | 1×VDX; | ||||
| Assess | ||||||
| Structure of zVDR LBD-Calcitriol in complex with chimera 10 | monomer | 1×VDX; | ||||
| Assess | ||||||
6 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8f5y.1.A | monomer | 0.59 | 40.50 | |||
| Assess | ||||||
| 4nqa.1.B | monomer | 0.59 | 1×ZN; | 32.45 | ||
| Assess | ||||||
| 4nqa.2.B | monomer | 0.58 | 2×ZN; | 32.45 | ||
| Assess | ||||||
| 3dzy.1.B | monomer | 0.55 | 1×ZN; | 27.64 | ||
| Assess | ||||||
| 7prv.1.B | monomer | 0.53 | 2×ZN; | 20.35 | ||
| Assess | ||||||
| 7prv.1.A | monomer | 0.53 | 2×ZN; | 20.35 | ||
| Assess | ||||||